10 June 2021 Investment Comments
Investment Comment June 2021

Markets were unsettled in May, with the main equity indices outside Europe ending the month in negative territory. Significant volatility returned to cryptocurrency markets, while commodities also experienced larger price swings than seen for many years. Inflation continued to be…

Investment Comment May 2021

Covid-19 showed no sign of leaving international headlines in April, one year on from the first full month most European countries spent in lockdown. India, in particular, bore the brunt of a resurgence, leading to intense pressure on hospitals. By…

Investment Comment April 2021

Markets remained unsettled in March by the rise in US Treasury yields and concurrent rise in inflation expectations. This has broad implications across equity, bond and commodity markets. With much of the developed world sovereign debt market yielding below zero in real terms…

Investment Comment March 2021

In February, optimism surrounding the global vaccine rollout and renewed inflation expectations combined to drive up bond yields and cyclical stocks. This came at the expense of previously favoured growth equities, some of which suffered their worst month since last…

Investment Comment February 2021

After an eventful 2020, the New Year began with several major changes. Joseph Biden was inaugurated as the 46th President of the United States amid protests in Washington. Britain officially left the European Union transition period and trade began on…

Investment Comment January 2021

December saw a resurgence in coronavirus disruption worldwide, leading governments to impose travel restrictions and lockdowns. A new variant of the virus was detected in the UK, prompting European countries to restrict travel to and from the country. Meanwhile, the…

Investment Comment December 2020

November was an eventful month for capital markets. Joseph Biden won the US Presidential election, and there were breakthrough trial results of Covid-19 vaccinations from Pfizer/BioNTech and Moderna, which both recorded over 90% effectiveness. Equity markets rallied globally, with the…

Investment Comment November 2020

Coronavirus cases continued to rise globally in October, and several countries saw a return of lockdown measures aimed at containing the virus. Political events continue to influence markets and macroeconomic developments, as epidemiological changes force governments around the world to…

Page 1 of 30